AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (March 16, 2007). doi:10.1152/ajpheart.01318.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/1/H385    most recent
01318.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yano, N.
Right arrow Articles by Tseng, Y.-T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yano, N.
Right arrow Articles by Tseng, Y.-T.
Submitted on December 1, 2006
Accepted on March 10, 2007

A Novel Signaling Pathway for {beta}-Adrenergic Receptor-Mediated Activation of Phosphoinositide 3-Kinase in H9c2 Cardiomyocytes

Naohiro Yano1, Vlad Ianus1, Ting C Zhao1, Andy Tseng2, James F Padbury1, and Yi-Tang Tseng1*

1 Pediatrics, Women & Infant's Hospital, Brown Medical School, Providence, Rhode Island, United States
2 Pediatrics, Women & Infant's Hospital, Brown Medical School, PROVIDENCE, Rhode Island, United States

* To whom correspondence should be addressed. E-mail: ytseng{at}wihri.org.

Stimulation of cardiac {beta}-adrenergic receptors ({beta}AR) activates both the Gs- and Gi-coupled signaling cascades, including the PI3K pathway, that have important physiological implications. Multiple isoforms of PI3K exist in the heart. The goals of this study were to examine the intracellular signaling pathways linking {beta}AR to PI3K and to identify the PI3K isoform mediating this transactivation in a cardiac context. Acute {beta}AR stimulation with isoproterenol resulted in increased tyrosine kinase-associated PI3K activity and phosphorylation of Akt and p70S6K in H9c2 cardiomyocytes. Co-treatment with ICI 118,551, but not CGP 20712, abolished the increase in PI3K activity, suggesting a {beta}2AR-mediated event. PI3K activation was also abrogated by co-treatment with pertussis toxin, PP2 (selective Src-family tyrosine kinases inhibitor), or AG1296 (selective PDGFR inhibitor) but not with an inhibitor for PKA, PKC, Ras, adenylyl cyclase, EGFR or IGF-1R. {beta}AR stimulation induced an increase in tyrosine phosphorylation of PDGFR, which was abolished by inhibition of Src either by PP2 or siRNA. Moreover, H9c2 cardiomyocytes stably transfected with a vector expressing a G{beta}{gamma} sequestrant peptide derived from the C-terminus of {beta}AR kinase-1 failed to activate PI3K after {beta}AR stimulation, suggesting G{beta}{gamma} is required for the transactivation. Furthermore, acute {beta}AR stimulation in vivo resulted in increases in PDGFR-associated PI3K and PI3K{alpha} isoform activities but not the activities of other isoforms (PI3K{beta}, -{delta}, -{gamma}) in adult mouse heart. Taken together, these data provide in vitro and in vivo evidence for a novel mechanism of {beta}AR-mediated transactivation of cardiac PI3K{alpha} via sequential involvement of G{alpha}i/G{beta}{gamma}, Src and PDGFR.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.